Bio Techne | TECH

Stock Price
62.68
Daily Change
-0.91 -1.43%
Monthly
-9.45%
Yearly
-20.39%
Q2 Forecast
69.05
Peers Price Chg Day Year Date
A Agilent 136.33 -1.22 -0.89% 2.41% Apr/25
BDX Becton, Dickinson and Co. 230.77 -3.18 -1.36% -10.73% Apr/25
BIO Bio-Rad Laboratories 275.46 -2.84 -1.02% -36.82% Apr/25
BRKR Bruker 80.53 -1.67 -2.03% 3.92% Apr/25
CRL Charles River Laboratories 227.76 -11.87 -4.95% 21.79% Apr/25
CTLT Catalent 55.80 -0.14 -0.25% 31.73% Apr/25
DHR Danaher 245.47 -4.90 -1.96% 5.59% Apr/25
EXAS Exact Sciences 58.79 -4.45 -7.04% -6.21% Apr/25
FLDM Standard Biotools 2.36 -0.06 -2.48% 43.03% Apr/25
HOLX Hologic 75.71 -1.07 -1.39% -10.84% Apr/25
ILMN Illumina 121.03 -1.85 -1.51% -42.63% Apr/25
IQV IQVIA Holdings 233.48 -7.37 -3.06% 22.90% Apr/25
MRK Merck 151.90 1.80 1.20% -5.30% Apr/26
MTD Mettler Toledo International 1,234.98 0.28 0.02% -15.51% Apr/25
PKI Revvity 102.32 -0.52 -0.51% -19.76% Apr/25
RGEN Repligen 165.70 -2.16 -1.29% 11.48% Apr/25
TECH Bio Techne 62.68 -0.91 -1.43% -20.39% Apr/25
TMO Thermo Fisher Scientific 571.73 -6.35 -1.10% 7.24% Apr/25
WAT Waters 308.53 -1.57 -0.51% 5.40% Apr/25

Indexes Price Day Year Date
CCMP USND 15612 -100.99 -0.64% 31.70% Apr/25
MID US400 2887 -13.99 -0.48% 18.79% Apr/25
SPX US500 5085 -23.21 -0.46% 22.95% Apr/26

Bio Techne traded at $62.68 this Thursday April 25th, decreasing $0.91 or 1.43 percent since the previous trading session. Looking back, over the last four weeks, Bio Techne lost 9.45 percent. Over the last 12 months, its price fell by 20.39 percent. Looking ahead, we forecast Bio Techne to be priced at 69.05 by the end of this quarter and at 65.16 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.